OAK BROOK, Ill. -- PureCircle (LSE: PURE), the world's leading producer of high purity stevia products, says the US Food and Drug Administration (FDA) has issued a No Objection letter for the use of PureCircle's SG95 product as a Food and Beverage ingredient in the USA. This will enable PureCircle to offer a wider and more flexible array of stevia solutions to manufacturers in the US market.
PureCircle's high purity SG95 product is a further example of the company's leadership in innovation. Along with seven previously approved steviol glycosides, SG95 includes two new steviol glycosides, Rebaudioside D and Rebaudioside F, both of which are receiving GRAS No Objection for the first time. The new high purity sweetener delivers great taste and con-sistency, as well as pricing well below sugar. The product is ideally suited for applications formulated with both sugar and SG95 to achieve a low cost solution to partial sugar and calo-rie reduction. Together with PureCircle's successful high purity Reb A 97, SG95 will provide customers with an expanded range of options to improve products across their portfolios. With GRAS affirmation, PureCircle is prepared for immediate commercialization of SG95.
